Full Text View
Tabular View
No Study Results Posted
Related Studies
Platelet Rich Plasma Study in Lower Extremity Bypass Surgery (PRP)
This study is ongoing, but not recruiting participants.
First Received: August 16, 2007   No Changes Posted
Sponsor: Lawson Health Research Institute
Collaborator: Biomet, Inc.
Information provided by: Lawson Health Research Institute
ClinicalTrials.gov Identifier: NCT00517452
  Purpose

The use of platelet rich plasma will decrease wound infection postop.


Condition Phase
Atherosclerosis
 Phase II
Phase III

Study Type: Observational
Study Design: Natural History, Longitudinal, Defined Population, Prospective Study
Official Title: Phase 2-3 Observational Wound Care Study Comparing Application of Platelet Rich Plasma With Standard of Care Wound Closure in Vascular Patients Requiring a Groin Incision.

Resource links provided by NLM:

MedlinePlus related topics: Surgery
U.S. FDA Resources

Further study details as provided by Lawson Health Research Institute:

Enrollment: 80
Study Start Date: May 2007
Estimated Study Completion Date: August 2007
  Eligibility

Ages Eligible for Study:   35 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Vascular surgical patients scheduled for elective lower extremity bypass surgery,aortoiliac revascularizations and endovascular AAA repair requiring a groin incision Exclusion Criteria:Patients requiring emergent procedures, unable to give informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00517452

Sponsors and Collaborators
Lawson Health Research Institute
Biomet, Inc.
Investigators
Principal Investigator: Kirk D Lawlor London Health Sciences Centre, University of Western Ontario
  More Information

No publications provided

Study ID Numbers: R-07-098
Study First Received: August 16, 2007
Last Updated: August 16, 2007
ClinicalTrials.gov Identifier: NCT00517452     History of Changes
Health Authority: Canada: Health Canada

Additional relevant MeSH terms:
Arterial Occlusive Diseases
Atherosclerosis
Vascular Diseases
Cardiovascular Diseases
Arteriosclerosis

ClinicalTrials.gov processed this record on November 27, 2009



Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services